Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (140)

1

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

enthalten in: Leukemia & lymphoma | 2019

von Holmström, M. | Novotny, G. | Petersen, J. | +6

2

Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

enthalten in: Haematologica | 2019

von Hasselbalch, H.

CommentOn: Haematologica. 2019 Nov;104(11):2200-2205. - PMID 30948488

3

Therapeutic cancer vaccination for treatment of haematological cancers

enthalten in: Ugeskrift for laeger | 2019

von Holmström, M. | Grauslund, J. | Dahlager-Jørgensen, N. | +3

4

Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis

enthalten in: Leukemia & lymphoma | 2019

von Bjørn, M. | Brimnes, M. | Gudbrandsdottir, S. | +5

5

Association of the blood eosinophil count with end-organ symptoms

enthalten in: Annals of medicine and surgery (2012) | 2019

von Bjerrum, O. | Siersma, V. | Hasselbalch, H. | +2

6

Smoking and Increased White and Red Blood Cells

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2019

von Pedersen, K. | Çolak, Y. | Ellervik, C. | +3

7

Cancer immune therapy for the treatment of haematological malignancies

enthalten in: Ugeskrift for laeger | 2019

von Holmström, M. | Klausen, U. | Jørgensen, N. | +8

8

Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms : a nationwide population-based survey in Denmark

enthalten in: Clinical epidemiology | 2019

von Brochmann, N. | Flachs, E. | Christensen, A. | +6

9

Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms - Impact Of Comorbidity

enthalten in: Clinical epidemiology | 2019

von Frederiksen, H. | Szépligeti, S. | Bak, M. | +3

10

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms : minimal residual disease and cure?

enthalten in: Seminars in immunopathology | 2019

von Hasselbalch, H. | Holmström, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]